Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP)

OBJECTIVE: To evaluate the effect of natalizumab on disability progression beyond 2 years of treatment in clinical practice. METHODS: Analyses included the 496 relapsing-remitting multiple sclerosis (RRMS) patients among 5122 patients in the Tysabri Observational Program (TOP) who had completed 4 co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiendl, Heinz, Butzkueven, Helmut, Kappos, Ludwig, Trojano, Maria, Pellegrini, Fabio, Paes, Dominic, Zhang, Annie, Belachew, Shibeshih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714845/
https://www.ncbi.nlm.nih.gov/pubmed/26771747
http://dx.doi.org/10.1371/journal.pone.0144834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714845/
https://www.ncbi.nlm.nih.gov/pubmed/26771747
http://dx.doi.org/10.1371/journal.pone.0144834

Ejemplares similares